tradingkey.logo

Iantrek Raises $42 Million Series C To Launch Alloflo™ Uveo, A Breakthrough Interventional Glaucoma Therapy

ReutersAug 20, 2025 12:17 PM

-

  • IANTREK RAISES $42 MILLION SERIES C TO LAUNCH ALLOFLO™ UVEO, A BREAKTHROUGH INTERVENTIONAL GLAUCOMA THERAPY

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI